Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Daily News

Use of DAPT Score Following PCI Validated in PRODIGY Study

Yael L. Maxwell

June 12, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Reason to SMILE? Single-Stage PCI Appears Safer Than Multiple Procedures for Multivessel NSTEMI

Yael L. Maxwell

January 20, 2016

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

L.A. McKeown

March 18, 2015

News Daily News

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

L.A. McKeown

January 12, 2015

News Daily News

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Yael L. Maxwell

October 03, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

Advertisement

What’s Going to Be Hot at TCT 2025

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Use of DAPT Score Following PCI Validated in PRODIGY Study

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Reason to SMILE? Single-Stage PCI Appears Safer Than Multiple Procedures for Multivessel NSTEMI

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

Delaying Noncardiac Surgery for 6 Months After Coronary Stenting May Reduce Complications

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content